| Active ingredient (INN) |
|---|
| Pegvisomant |
| Brand names | SOMAVERT pegvisomant |
|---|
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | Pfizer Australia Pty Ltd |
|---|
| Registrations on file | 6 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| SOMAVERT pegvisomant | 10mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| SOMAVERT pegvisomant | 15mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| SOMAVERT pegvisomant | 20mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| SOMAVERT pegvisomant {rbe} | 10mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| SOMAVERT pegvisomant {rbe} | 15mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| SOMAVERT pegvisomant {rbe} | 20mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |